Benjamin Delprat
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Development of Second-Generation Phenoxyethylpiperidines as Potent Sigma-1 Receptor Agonists with Neuroprotective Potential for Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: February 05, 2026
Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 08, 2025
Positive modulation of sigma-1 receptor: a new weapon to mitigate disease progression in amyotrophic lateral sclerosis.
Journal: Translational neurodegeneration
Published: May 12, 2025
Improving mitochondria-associated endoplasmic reticulum membranes integrity as converging therapeutic strategy for rare neurodegenerative diseases and cancer.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: November 28, 2024
Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ 1 chaperone protein.
Journal: Acta pharmaceutica Sinica. B
Published: March 19, 2024
Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties.
Journal: Phytotherapy research : PTR
Published: August 02, 2023
Wfs1E864K knock-in mice illuminate the fundamental role of Wfs1 in endocochlear potential production.
Journal: Cell death & disease
Published: January 11, 2023
Calcium signaling and genetic rare diseases: An auditory perspective.
Journal: Cell calcium
Published: December 14, 2022
NCS1 overexpression restored mitochondrial activity and behavioral alterations in a zebrafish model of Wolfram syndrome.
Journal: Molecular therapy. Methods & clinical development
Published: February 21, 2022
Last Updated: 09/26/2026